1. Maggiorani, D, Santin, Y, Formoso, K, Douin-Echinard, V, Mialet-Perez, J. 2024. Identification of Prominin-2 as a new player of cardiomyocyte senescence in the aging heart. In Aging cell, 23, e14204. doi:10.1111/acel.14204. https://pubmed.ncbi.nlm.nih.gov/38757782/
2. Chen, Yiru, Li, Zihao, Cao, Qingtai, Mao, Longfei, Zhao, Mingyi. 2022. Ferroptosis-related gene signatures in neuroblastoma associated with prognosis. In Frontiers in cell and developmental biology, 10, 871512. doi:10.3389/fcell.2022.871512. https://pubmed.ncbi.nlm.nih.gov/36147739/
3. Jiang, Jun, Zhang, Chen, Wang, Jianfen, Wang, Xinyan, Mao, Peiyu. . Knockdown of PROM2 Enhances Paclitaxel Sensitivity in Endometrial Cancer Cells by Regulating the AKT/FOXO1 Pathway. In Anti-cancer agents in medicinal chemistry, 23, 2127-2134. doi:10.2174/1871520623666230905104555. https://pubmed.ncbi.nlm.nih.gov/37670696/
4. Wu, Kuan-Li, Chang, Chao-Yuan, Tsai, Ying-Ming, Tsai, Pei-Hsun, Hsu, Ya-Ling. 2024. PROM2 upregulation promotes cancer cell migration and confers a poor prognosis in lung squamous cell carcinoma. In American journal of cancer research, 14, 1561-1576. doi:10.62347/EQFY1219. https://pubmed.ncbi.nlm.nih.gov/38726259/